CVS Health CVS

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
-$0.49 (-0.72%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0

Relative Strength Index (RSI)

- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

- The RSI is calculated using the following formula:

RSI = 100 - (100 / (1 + RS))

Where RS is the ratio of the average gains to the average losses over a specified period.

- The default time period used is 14 days.

- RSI values range between 0 and 100.

RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

Key Insights

CVS Health (CVS) Core Market Data and Business Metrics
  • Latest Closing Price

    $68.07
  • Price-Earnings Ratio

    17.23
  • Total Outstanding Shares

    1.26 Billion Shares
  • Dividend

    $0.67 Per Share Quarterly
  • SIC Description

    Retail-drug Stores And Proprietary Stores
  • Primary Exchange

    New York Stock Exchange
  • Headquarters

    One Cvs Dr., Woonsocket, RI, 02895

Historical Stock Splits

If you bought 1 share of CVS before June 7, 2005, you'd have 2 shares today.
Execution DateSplit Amount
June 7, 20052-for-1

Short Interest

Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
Avg Daily VolumeDays to CoverSettlement DateShort Interest
7,965,639 Shares2.53/14/202519,880,048 Shares
9,582,082 Shares2.152/28/202520,554,799 Shares
13,555,203 Shares1.742/14/202523,600,102 Shares
12,163,107 Shares1.761/31/202521,351,591 Shares
14,877,388 Shares1.141/15/202516,990,142 Shares
17,450,510 Shares1.0412/31/202418,097,574 Shares

Cash Flow Statement

October 1, 2023 to September 30, 2024
MetricValue
Net Cash Flow From Investing Activities, Continuing$-8.31 Billion
Net Cash Flow$-6.24 Billion
Net Cash Flow, Continuing$-6.24 Billion
Net Cash Flow From Investing Activities$-8.31 Billion
Net Cash Flow From Financing Activities$-2.54 Billion
Net Cash Flow From Operating Activities$4.61 Billion

Income Statement

October 1, 2023 to September 30, 2024
MetricValue
Revenues$368.91 Billion
Net Income/Loss Available To Common Stockholders, Basic$5.02 Billion
Benefits Costs and Expenses$362.19 Billion
Net Income/Loss Attributable To Parent$5.02 Billion
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0
Basic Earnings Per Share$3.95

Comprehensive Income

October 1, 2023 to September 30, 2024
MetricValue
Other Comprehensive Income/Loss$1.21 Billion
Comprehensive Income/Loss Attributable To Noncontrolling Interest$-6 Million
Comprehensive Income/Loss Attributable To Parent$6.23 Billion
Comprehensive Income/Loss$6.22 Billion

Balance Sheet

October 1, 2023 to September 30, 2024
MetricValue
Noncurrent Liabilities$92.69 Billion
Equity Attributable To Noncontrolling Interest$162 Million
Current Assets$67.34 Billion
Inventory$17.65 Billion
Liabilities$177.32 Billion
Assets$252.43 Billion

Historical Dividends

Current dividend: $0.67 Per Share Quarterly
Announcement DatePayment DateRecord DateAmountFrequency
Mar 20, 2025May 1, 2025Apr 22, 2025$0.665Quarterly
Jan 3, 2025Feb 3, 2025Jan 23, 2025$0.665Quarterly
Sep 19, 2024Nov 1, 2024Oct 21, 2024$0.665Quarterly
Jul 8, 2024Aug 1, 2024Jul 22, 2024$0.665Quarterly
Mar 21, 2024May 1, 2024Apr 22, 2024$0.665Quarterly
Dec 5, 2023Feb 1, 2024Jan 22, 2024$0.665Quarterly

CVS Articles From Financhle

Recent analysis, market insights, and in-depth coverage of CVS from analysts at Financhle
  • CVS Health's Q4 FY2024 Earnings Report Unpacked: Triumphs, Trials, and Future ProspectsAnalyze CVS Health's Q4 FY2024 earnings through a lens of strategic nuance and market acumen. Click to understand the interplay of growth, challenges, and forward-thinking in one of healthcare's leading orchestrators.
    FinanchleFebruary 12, 2025

Recent Headlines From The Web

Latest news, press releases, and media coverage about CVS from trusted financial sources

    Related Companies

    Publicly traded companies similar to CVS Health (CVS)